These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

379 related articles for article (PubMed ID: 25688820)

  • 1. The effect of prophylactic intravenous tranexamic acid on blood loss after vaginal delivery in women at low risk of postpartum haemorrhage: a double-blind randomised controlled trial.
    Mirghafourvand M; Mohammad-Alizadeh S; Abbasalizadeh F; Shirdel M
    Aust N Z J Obstet Gynaecol; 2015 Feb; 55(1):53-8. PubMed ID: 25688820
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Can intravenous injection of tranexamic acid be used in routine practice with active management of the third stage of labor in vaginal delivery? A randomized controlled study.
    Gungorduk K; Asıcıoğlu O; Yıldırım G; Ark C; Tekirdağ Aİ; Besımoglu B
    Am J Perinatol; 2013 May; 30(5):407-13. PubMed ID: 23023559
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Study protocol. TRAAP - TRAnexamic Acid for Preventing postpartum hemorrhage after vaginal delivery: a multicenter randomized, double-blind, placebo-controlled trial.
    Sentilhes L; Daniel V; Darsonval A; Deruelle P; Vardon D; Perrotin F; Le Ray C; Senat MV; Winer N; Maillard F; Deneux-Tharaux C
    BMC Pregnancy Childbirth; 2015 Jun; 15():135. PubMed ID: 26071040
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of prophylactic oral tranexamic acid plus buccal misoprostol on blood loss after vaginal delivery: a randomized controlled trial.
    Shady NW; Sallam HF; Elsayed AH; Abdelkader AM; Ali SS; Alanwar A; Abbas AM
    J Matern Fetal Neonatal Med; 2019 Jun; 32(11):1806-1812. PubMed ID: 29241383
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic and pharmaco-biological, dose-ranging multicentre trial to determine the optimal dose of TRAnexamic acid to reduce blood loss in haemorrhagic CESarean delivery (TRACES): study protocol for a randomised, double-blind, placebo-controlled trial.
    Bouthors AS; Hennart B; Jeanpierre E; Baptiste AS; Saidi I; Simon E; Lannoy D; Duhamel A; Allorge D; Susen S
    Trials; 2018 Mar; 19(1):148. PubMed ID: 29490682
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tranexamic Acid for the Prevention of Blood Loss after Vaginal Delivery.
    Sentilhes L; Winer N; Azria E; Sénat MV; Le Ray C; Vardon D; Perrotin F; Desbrière R; Fuchs F; Kayem G; Ducarme G; Doret-Dion M; Huissoud C; Bohec C; Deruelle P; Darsonval A; Chrétien JM; Seco A; Daniel V; Deneux-Tharaux C;
    N Engl J Med; 2018 Aug; 379(8):731-742. PubMed ID: 30134136
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Carbetocin versus syntometrine for the third stage of labour following vaginal delivery--a double-blind randomised controlled trial.
    Su LL; Rauff M; Chan YH; Mohamad Suphan N; Lau TP; Biswas A; Chong YS
    BJOG; 2009 Oct; 116(11):1461-6. PubMed ID: 19538418
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The WOMAN Trial (World Maternal Antifibrinolytic Trial): tranexamic acid for the treatment of postpartum haemorrhage: an international randomised, double blind placebo controlled trial.
    Shakur H; Elbourne D; Gülmezoglu M; Alfirevic Z; Ronsmans C; Allen E; Roberts I
    Trials; 2010 Apr; 11():40. PubMed ID: 20398351
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intramuscular oxytocin versus intravenous oxytocin to prevent postpartum haemorrhage at vaginal delivery (LabOR trial): study protocol for a randomised controlled trial.
    Adnan N; Boland F; Murphy DJ
    Trials; 2017 Nov; 18(1):541. PubMed ID: 29141679
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of early tranexamic acid administration on mortality, hysterectomy, and other morbidities in women with post-partum haemorrhage (WOMAN): an international, randomised, double-blind, placebo-controlled trial.
    WOMAN Trial Collaborators
    Lancet; 2017 May; 389(10084):2105-2116. PubMed ID: 28456509
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of post-partum haemorrhage with sublingual misoprostol versus oxytocin in women receiving prophylactic oxytocin: a double-blind, randomised, non-inferiority trial.
    Blum J; Winikoff B; Raghavan S; Dabash R; Ramadan MC; Dilbaz B; Dao B; Durocher J; Yalvac S; Diop A; Dzuba IG; Ngoc NT
    Lancet; 2010 Jan; 375(9710):217-23. PubMed ID: 20060162
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of intravenous tranexamic acid administration on blood loss during and after cesarean delivery.
    Movafegh A; Eslamian L; Dorabadi A
    Int J Gynaecol Obstet; 2011 Dec; 115(3):224-6. PubMed ID: 21872857
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prospective randomized trial of oxytocin administration for active management of the third stage of labor.
    Oguz Orhan E; Dilbaz B; Aksakal SE; Altınbas S; Erkaya S
    Int J Gynaecol Obstet; 2014 Nov; 127(2):175-9. PubMed ID: 25108586
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intramuscular oxytocin administration before vs. after placental delivery for the prevention of postpartum hemorrhage: A randomized controlled prospective trial.
    Yildirim D; Ozyurek SE
    Eur J Obstet Gynecol Reprod Biol; 2018 May; 224():47-51. PubMed ID: 29533864
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of post-partum haemorrhage with sublingual misoprostol versus oxytocin in women not exposed to oxytocin during labour: a double-blind, randomised, non-inferiority trial.
    Winikoff B; Dabash R; Durocher J; Darwish E; Nguyen TN; León W; Raghavan S; Medhat I; Huynh TK; Barrera G; Blum J
    Lancet; 2010 Jan; 375(9710):210-6. PubMed ID: 20060161
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A randomized trial of sublingual misoprostol to augment routine third-stage management among women at risk of postpartum hemorrhage.
    Chaudhuri P; Majumdar A
    Int J Gynaecol Obstet; 2016 Feb; 132(2):191-5. PubMed ID: 26613819
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Utilization of carbetocin for prevention of postpartum hemorrhage after cesarean section: a randomized clinical trial.
    Borruto F; Treisser A; Comparetto C
    Arch Gynecol Obstet; 2009 Nov; 280(5):707-12. PubMed ID: 19229549
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tranexamic acid for the prevention of postpartum hemorrhage after cesarean section: a double-blind randomization trial.
    Xu J; Gao W; Ju Y
    Arch Gynecol Obstet; 2013 Mar; 287(3):463-8. PubMed ID: 23064441
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevention of postpartum hemorrhage by uterotonic agents: comparison of oxytocin and methylergometrine in the management of the third stage of labor.
    Fujimoto M; Takeuchi K; Sugimoto M; Maruo T
    Acta Obstet Gynecol Scand; 2006; 85(11):1310-4. PubMed ID: 17091409
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tranexamic acid for the prevention of postpartum bleeding in women with anaemia: study protocol for an international, randomised, double-blind, placebo-controlled trial.
    Ker K; Roberts I; Chaudhri R; Fawole B; Beaumont D; Balogun E; Prowse D; Pepple T; Javaid K; Kayani A; Arulkumaran S; Bates I; Shakur-Still H;
    Trials; 2018 Dec; 19(1):712. PubMed ID: 30594227
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.